Grifols considers a potential US IPO of its US biopharma unit as part of its self-sufficiency plan. Read more here. Spanish pharma Grifols, S.A. (GRFS) said that its board has decided to evaluate a po...
Spanish drugmaker Grifols said on Tuesday it has approved a U.S. initial public offering of its U.S. biopharma business. Grifols, which makes drugs using blood plasma, plans to float a minority sta...
